JOYN Advisors’s Regenxbio RGNX Stock Holding History

JOYN Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	–	–	1105
2018 Q4	$0	Buy	4 +1	+33%	+$59	﹤0.01%	1859
2018 Q3	$0	Buy	+3	New	+$216	﹤0.01%	1858

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JOYN Advisors's RGNX Position: Q1 2019 in Review

JOYN Advisors sold out of Regenxbio (RGNX) in Q1 2019, closing a stake of 4 shares.

JOYN Advisors first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $0 in Q4 2018. 211 funds tracked by Wall St. Rank hold RGNX as of Q1 2019.

JOYN Advisors reported no remaining Regenxbio position as of Q1 2019 after selling out during the quarter.
JOYN Advisors sold 4 Regenxbio shares in Q1 2019.
JOYN Advisors first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
JOYN Advisors's Regenxbio position peaked at $0 in Q4 2018.
211 funds tracked by Wall St. Rank held Regenxbio as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.